X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10581) 10581
Newspaper Article (268) 268
Newsletter (167) 167
Book Chapter (71) 71
Government Document (16) 16
Magazine Article (14) 14
Conference Proceeding (10) 10
Book / eBook (8) 8
Trade Publication Article (5) 5
Reference (4) 4
Dissertation (3) 3
Transcript (2) 2
Book Review (1) 1
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6771) 6771
animals (6308) 6308
neurosciences (4066) 4066
huntingtons-disease (3781) 3781
huntington's disease (3139) 3139
male (3058) 3058
mice (2966) 2966
huntington disease - metabolism (2731) 2731
female (2173) 2173
huntington disease - genetics (2132) 2132
biochemistry & molecular biology (2063) 2063
disease models, animal (2044) 2044
neurodegeneration (1730) 1730
huntington's chorea (1728) 1728
huntington disease - pathology (1670) 1670
rats (1612) 1612
brain (1568) 1568
nerve tissue proteins - genetics (1477) 1477
proteins (1441) 1441
neurons - metabolism (1422) 1422
huntingtin protein (1401) 1401
neurodegenerative diseases (1397) 1397
nerve tissue proteins - metabolism (1393) 1393
neurons (1385) 1385
nervous system diseases (1370) 1370
brain - metabolism (1331) 1331
huntingtons disease (1328) 1328
middle aged (1268) 1268
mice, transgenic (1259) 1259
neurology (1246) 1246
alzheimers-disease (1229) 1229
analysis (1198) 1198
mutation (1191) 1191
cell biology (1170) 1170
clinical neurology (1169) 1169
adult (1161) 1161
mutant huntingtin (1144) 1144
parkinsons-disease (1129) 1129
oxidative stress (1059) 1059
huntington disease - physiopathology (1029) 1029
mouse model (1018) 1018
nuclear proteins - genetics (1013) 1013
research (972) 972
alzheimer's disease (960) 960
nervous system (958) 958
huntington’s disease (901) 901
parkinson's disease (899) 899
nuclear proteins - metabolism (883) 883
aged (880) 880
huntington disease (878) 878
apoptosis (874) 874
corpus striatum - metabolism (856) 856
gene expression (808) 808
huntingtin (806) 806
genetics & heredity (782) 782
physiological aspects (771) 771
transgenic mice (761) 761
neurons - pathology (759) 759
disease (755) 755
expression (754) 754
brain - pathology (750) 750
cells, cultured (750) 750
polyglutamine (748) 748
metabolism (720) 720
multidisciplinary sciences (717) 717
huntington disease - drug therapy (709) 709
pharmacology & pharmacy (689) 689
neurodegenerative diseases - metabolism (667) 667
genetic aspects (650) 650
peptides - metabolism (630) 630
rodents (630) 630
mice, inbred c57bl (629) 629
mitochondria (612) 612
basal ganglia (611) 611
research article (599) 599
neurons - drug effects (589) 589
in-vivo (588) 588
striatum (584) 584
medicine (562) 562
immunohistochemistry (560) 560
amyotrophic-lateral-sclerosis (548) 548
cell line (543) 543
medical research (526) 526
corpus striatum - pathology (516) 516
neuroprotection (516) 516
biology (515) 515
cell-death (511) 511
neuronal intranuclear inclusions (508) 508
protein (505) 505
health aspects (504) 504
mitochondria - metabolism (491) 491
autophagy (488) 488
mental disorders (485) 485
gene-expression (479) 479
rats, sprague-dawley (474) 474
quinolinic acid (470) 470
pathogenesis (469) 469
corpus striatum - drug effects (467) 467
gene (466) 466
pathology (463) 463
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11024) 11024
Japanese (35) 35
German (31) 31
French (27) 27
Spanish (26) 26
Russian (23) 23
Italian (12) 12
Polish (12) 12
Chinese (9) 9
Portuguese (7) 7
Norwegian (4) 4
Swedish (4) 4
Hungarian (3) 3
Danish (2) 2
Dutch (2) 2
Turkish (2) 2
Croatian (1) 1
Czech (1) 1
Hebrew (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the neurological sciences, ISSN 0022-510X, 2012, Volume 323, Issue 1-2, pp. 1 - 8
...), Parkinson's disease (PD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS). Several studies have demonstrated that altered kynurenine metabolism plays an important role in the pathogenesis of this group of diseases... 
Neurology | Aging | Alzheimer's disease (AD) | Amyotrophic lateral sclerosis (ALS) | Huntington's disease (HD) | Parkinson's disease (PD) | Kynurenine pathway | TRYPTOPHAN-METABOLISM | ACID | ALZHEIMERS-DISEASE | INDOLEAMINE 2,3-DIOXYGENASE | DISORDERS | NEUROSCIENCES | CLINICAL NEUROLOGY | QUINOLINATE LEVELS | CELL-DEATH | 3-MONOOXYGENASE | BRAIN | PARKINSONS-DISEASE | Indoleamine-Pyrrole 2,3,-Dioxygenase - metabolism | Neuroprotective Agents - therapeutic use | Microglia - metabolism | Kynurenine - therapeutic use | Humans | Neurodegenerative Diseases - prevention & control | Parkinson Disease - drug therapy | Kynurenic Acid - metabolism | Molecular Targeted Therapy | Neurodegenerative Diseases - drug therapy | Quinolinic Acid - antagonists & inhibitors | Tryptophan - metabolism | Amyotrophic Lateral Sclerosis - drug therapy | Inflammation - metabolism | Neuroprotective Agents - pharmacology | Alzheimer Disease - prevention & control | Neurons - metabolism | Parkinson Disease - metabolism | Kynurenine - metabolism | Huntington Disease - drug therapy | Receptors, G-Protein-Coupled - drug effects | Receptors, G-Protein-Coupled - physiology | Receptors, N-Methyl-D-Aspartate - drug effects | Kynurenine - pharmacology | Enzyme Inhibitors - pharmacology | Alzheimer Disease - drug therapy | Neurodegenerative Diseases - metabolism | Enzyme Inhibitors - therapeutic use | Huntington Disease - metabolism | Kynurenine - analogs & derivatives | Receptors, N-Methyl-D-Aspartate - physiology | Parkinson Disease - prevention & control | Animals | Quinolinic Acid - metabolism | Alzheimer Disease - metabolism | Amyotrophic Lateral Sclerosis - metabolism | Neurotoxins - metabolism | Kynurenic Acid - antagonists & inhibitors | Aging - metabolism | Enzymes | Nervous system diseases | Enzyme inhibitors | Parkinson's disease | Metabolites | Huntington's chorea | Analysis | Physiological aspects | Tryptophan | Amyotrophic lateral sclerosis | Health aspects | Alzheimer's disease | Index Medicus
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 2002, Volume 296, Issue 5575, pp. 1991 - 1995
...Neurodegenerative disorders as diverse as Alzheimer's disease, Parkinson's disease, priori diseases, Huntington's disease, frontotemporal dementia, and motor... 
Nervous system diseases | Reviews | Neurodegenerative diseases | Disease models | Huntington disease | Parkinson disease | Prion diseases | Amyotrophic lateral sclerosis | Nervous system heredodegenerative disorders | Alzheimers disease | Genetic mutation | Parkinson Disease - therapy | Neurons - pathology | Prion Diseases - genetics | Humans | Peptides - genetics | Tauopathies - pathology | Alzheimer Disease - pathology | Peptides - metabolism | Tauopathies - therapy | Neurons - metabolism | Parkinson Disease - metabolism | Inclusion Bodies - metabolism | Prion Diseases - therapy | Parkinson Disease - pathology | Neurodegenerative Diseases - pathology | Amyotrophic Lateral Sclerosis - therapy | Amyotrophic Lateral Sclerosis - genetics | Alzheimer Disease - therapy | Neurodegenerative Diseases - genetics | Neurodegenerative Diseases - therapy | Prion Diseases - pathology | Neurodegenerative Diseases - metabolism | Parkinson Disease - genetics | Protein Folding | Trinucleotide Repeat Expansion | Proteins - genetics | Amyotrophic Lateral Sclerosis - pathology | Tauopathies - metabolism | Animals | Proteins - metabolism | Alzheimer Disease - metabolism | Amyotrophic Lateral Sclerosis - metabolism | Mutation | Proteins - chemistry | Alzheimer Disease - genetics | Prion Diseases - metabolism | Parkinson's disease | Nervous system | Degeneration | Research | Alzheimer's disease | Proteins | Neurological disorders
Journal Article
Journal Article
Journal Article
Experimental & molecular medicine, ISSN 2092-6413, 2015, Volume 47, Issue 3, pp. e147 - e147
Mammalian cells remove misfolded proteins using various proteolytic systems, including the ubiquitin (Ub)-proteasome system (UPS), chaperone mediated autophagy... 
MEDICINE, RESEARCH & EXPERIMENTAL | UBIQUITIN-PROTEASOME SYSTEM | CHAPERONE-MEDIATED AUTOPHAGY | ALPHA-SYNUCLEIN AGGREGATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | QUALITY CONTROL DEGRADATION | CENTRAL-NERVOUS-SYSTEM | AMYOTROPHIC-LATERAL-SCLEROSIS | SOD1 TRANSGENIC MICE | ENDOPLASMIC-RETICULUM STRESS | END RULE PATHWAY | PARKINSONS-DISEASE | Proteostasis Deficiencies - metabolism | Humans | Ubiquitin - metabolism | tau Proteins - metabolism | Parkinson Disease - drug therapy | Molecular Targeted Therapy | Neurodegenerative Diseases - drug therapy | Amyotrophic Lateral Sclerosis - drug therapy | Autophagy - drug effects | DNA-Binding Proteins - metabolism | PrPSc Proteins - metabolism | Lysosomes - metabolism | Proteolysis | Amyloid beta-Peptides - metabolism | Parkinson Disease - metabolism | Huntington Disease - drug therapy | Superoxide Dismutase - metabolism | Prion Diseases - drug therapy | Alzheimer Disease - drug therapy | Neurodegenerative Diseases - metabolism | Huntington Disease - metabolism | Nerve Tissue Proteins - genetics | Nerve Tissue Proteins - metabolism | Huntingtin Protein | Animals | Alzheimer Disease - metabolism | Amyotrophic Lateral Sclerosis - metabolism | Huntington Disease - genetics | Mutation | Proteasome Endopeptidase Complex - metabolism | alpha-Synuclein - metabolism | Prion Diseases - metabolism | Review
Journal Article